UK MHRA Updated Managing Clinical Trials During Coronavirus (COVID-19)

On 8 September 2021 the UK MHRA updated guidance on managing clinical trials during COVID-19.

This guidance has been developed to assist those involved in clinical trials disrupted as a result of COVID-19. It is relevant to those involved with ongoing studies, those wishing to restart trials that have been paused or temporarily halted, and those wishing to start new studies.

This guidance will be updated as the situation changes over time.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /